5.Disclosures in accordance with art. 964b Swiss Code of Obligations
The following sections comprise the report on non-financial matters in accordance with art. 964b of the Swiss Code of Obligations (the “CO”), which includes an independent practitioner’s limited assurance report on selected non-financial information, including a selected set of performance indicators. The consultative vote on the report on non-financial matters for the financial year 2023 at the 2024 annual general meeting is limited to the content of these sections.
|
Art. 964b CO content requirement |
Section |
Reference |
Article links |
|
|
|
|
|
|
General information required to understand our business |
Introduction |
Page 18 |
|
|
Sustainability approach |
Page 19-22 |
||
|
Overview–Strategy |
Page 9-11 |
||
|
|
Reporting on the material ESG topics |
Page 26-41 |
|
|
Description of the business model |
Introduction |
Page 18 |
|
|
|
Overview–Strategy–Business model |
Page 9-11 |
|
|
Description of materiality assessment |
Materiality and contribution to the SDGs–Identification of material topics |
Page 23 |
https://report.polypeptide.com/ar/23/en/?p=1814/#identificationofmaterialtopics |
|
|
Materiality and contribution to the SDGs–Materiality matrix |
Page 24 |
https://report.polypeptide.com/ar/23/en/?p=1814/#materialitymatrix |
|
|
Reporting on the material ESG topics |
Page 26-41 |
|
|
Description of governance |
Sustainability approach–Responsibilities and organization |
Page 19-20 |
https://report.polypeptide.com/ar/23/en/?p=1808/#responsibilitiesandorganization |
|
Environmental matters (in particular CO2 goals) |
Green chemistry |
Page 29-31 |
https://report.polypeptide.com/ar/23/en/?p=1811/#greenchemistry |
|
|
Climate change mitigation |
Page 32-34 |
https://report.polypeptide.com/ar/23/en/?p=1811/#climatechangemitigation |
|
Main impacts, risks and opportunities |
Green chemistry–Impact |
Page 29 |
https://report.polypeptide.com/ar/23/en/?p=1811/#greenchemistryimpact |
|
|
Climate change mitigation–Impact |
Page 32 |
https://report.polypeptide.com/ar/23/en/?p=1811/#climatechangemitigationimpact |
|
|
Green chemistry–Risks and opportunities |
Page 29 |
https://report.polypeptide.com/ar/23/en/?p=1811/#greenchemistryrisksandopportunities |
|
|
Climate change mitigation–Risks and opportunities |
Page 32 |
https://report.polypeptide.com/ar/23/en/?p=1811/#climatechangemitigationrisksandopportunities |
|
Policies adopted, including the due diligence applied |
Green chemistry–Approach–Policies and commitments |
Page 30 |
https://report.polypeptide.com/ar/23/en/?p=1811/#greenchemistrypolociesandcommitments |
|
Climate change mitigation–Approach–Policies and commitments |
Page 32 |
https://report.polypeptide.com/ar/23/en/?p=1811/#climatechangemitigationpoliciesandcommitments |
|
|
Measures taken to implement policies and assessment of effectiveness |
Green chemistry–Approach–Management of impacts, risks and opportunities |
Page 30-31 |
https://report.polypeptide.com/ar/23/en/?p=1811/#greenchemistrymanagement |
|
|
Green chemistry–Approach–Achievements and challenges in 2023 |
Page 31 |
https://report.polypeptide.com/ar/23/en/?p=1811/#greenchemistryachievements2023 |
|
|
Climate change mitigation–Approach–Management of impacts, risks and opportunities |
Page 33 |
https://report.polypeptide.com/ar/23/en/?p=1811/#climatechangemitigationmanagement |
|
|
Climate change mitigation–Approach–Achievements and challenges in 2023 |
Page 33-34 |
https://report.polypeptide.com/ar/23/en/?p=1811/#climatechangemitigationachievements2023 |
|
Performance indicators |
Green chemistry–Approach–Achievements and challenges in 2023 |
Page 31 |
https://report.polypeptide.com/ar/23/en/?p=1811/#greenchemistryachievements2023 |
|
|
Climate change mitigation–Approach–Achievements and challenges in 2023 |
Page 33-34 |
https://report.polypeptide.com/ar/23/en/?p=1811/#climatechangemitigationachievements2023 |
|
Social issues |
Product responsibility |
Page 27-29 |
https://report.polypeptide.com/ar/23/en/?p=1811/#productresponsibility |
|
|
People |
Page 36-39 |
|
|
Main impacts, risks and opportunities |
Product responsibility–Impact |
Page 27 |
https://report.polypeptide.com/ar/23/en/?p=1811/#productresponsibilityimpact |
|
|
People–Impact |
Page 36 |
https://report.polypeptide.com/ar/23/en/?p=1811/#peopleimpact |
|
|
Product responsibility–Risks and opportunities |
Page 27 |
https://report.polypeptide.com/ar/23/en/?p=1811/#productresponsibilityrisksandopportunities |
|
|
People–Risks and opportunities |
Page 36 |
https://report.polypeptide.com/ar/23/en/?p=1811/#peoplerisksandopportunities |
|
Policies adopted, including the due diligence applied |
Product responsibility–Approach–Policies and commitments |
Page 27 |
https://report.polypeptide.com/ar/23/en/?p=1811/#productresponsibilitypoliciesandcommitments |
|
People–Approach–Policies and commitments |
Page 36-37 |
https://report.polypeptide.com/ar/23/en/?p=1811/#peoplepoliciesandcommitments |
|
|
Measures taken to implement policies and assessment of effectiveness |
Product responsibility–Approach–Management of impacts, risks and opportunities |
Page 28 |
https://report.polypeptide.com/ar/23/en/?p=1811/#productresponsibilitymanagement |
|
Product responsibility–Approach–Achievements and challenges in 2023 |
Page 28-29 |
https://report.polypeptide.com/ar/23/en/?p=1811#peopleresponsibilityachievements2023 |
|
|
People–Approach–Management of impacts, risks and opportunities |
Page 37 |
https://report.polypeptide.com/ar/23/en/?p=1811/#peoplemanagement |
|
|
|
People–Approach–Achievements and challenges in 2023 |
Page 37-39 |
https://report.polypeptide.com/ar/23/en/?p=1811/#peopleachievements2023 |
|
Performance indicators |
Product responsibility–Approach–Achievements and challenges in 2023 |
Page 28-29 |
https://report.polypeptide.com/ar/23/en/?p=1811#peopleresponsibilityachievements2023 |
|
|
People–Approach–Achievements and challenges in 2023 |
Page 37-39 |
https://report.polypeptide.com/ar/23/en/?p=1811/#peopleachievements2023 |
|
Employee-related issues |
People |
Page 36-39 |
|
|
Main impacts, risks and opportunities |
People–Impact |
Page 36 |
https://report.polypeptide.com/ar/23/en/?p=1811/#peopleimpact |
|
|
People–Risks and opportunities |
Page 36 |
https://report.polypeptide.com/ar/23/en/?p=1811/#peoplerisksandopportunities |
|
Policies adopted, including the due diligence applied |
People–Approach–Policies and commitments |
Page 36-37 |
https://report.polypeptide.com/ar/23/en/?p=1811/#peoplepoliciesandcommitments |
|
Measures taken to implement policies and assessment of effectiveness |
People–Approach–Management of impacts, risks and opportunities |
Page 37 |
https://report.polypeptide.com/ar/23/en/?p=1811/#peoplemanagement |
|
|
People–Approach–Achievements and challenges in 2023 |
Page 37-39 |
https://report.polypeptide.com/ar/23/en/?p=1811/#peopleachievements2023 |
|
Performance indicators |
People–Approach–Achievements and challenges in 2023 |
Page 37-39 |
https://report.polypeptide.com/ar/23/en/?p=1811/#peopleachievements2023 |
|
Respect for human rights |
Supply chain engagement |
Page 34-36 |
https://report.polypeptide.com/ar/23/en/?p=1811/#supplychainengagement |
|
|
People |
Page 36-39 |
|
|
Main impacts, risks and opportunities |
Supply chain engagement–Impact |
Page 34 |
https://report.polypeptide.com/ar/23/en/?p=1811/#supplychainengagementimpact |
|
People–Impact |
Page 36 |
https://report.polypeptide.com/ar/23/en/?p=1811/#peopleimpact |
|
|
Supply chain engagement–Risks and opportunities |
Page 34-35 |
https://report.polypeptide.com/ar/23/en/?p=1811/#supplychainengagementrisksandopportunities |
|
|
|
People–Risks and opportunities |
Page 36 |
https://report.polypeptide.com/ar/23/en/?p=1811/#peoplerisksandopportunities |
|
Policies adopted, including the due diligence applied |
Supply chain engagement–Approach–Policies and commitments |
Page 35 |
https://report.polypeptide.com/ar/23/en/?p=1811/#supplychainengagementpoliciesandcommitments |
|
People–Approach–Policies and commitments |
Page 36-37 |
https://report.polypeptide.com/ar/23/en/?p=1811/#peoplepoliciesandcommitments |
|
|
Measures taken to implement policies and assessment of effectiveness |
Supply chain engagement–Approach–Management of impacts, risks and opportunities |
Page 35 |
https://report.polypeptide.com/ar/23/en/?p=1811/#supplychainengagementmanagement |
|
Supply chain engagement–Approach–Achievements and challenges in 2023 |
Page 36 |
https://report.polypeptide.com/ar/23/en/?p=1811/#supplychainengagementachievements2023 |
|
|
People–Approach–Management of impacts, risks and opportunities |
Page 37 |
https://report.polypeptide.com/ar/23/en/?p=1811/#peoplemanagement |
|
|
|
People–Approach–Achievements and challenges in 2023 |
Page 37-39 |
https://report.polypeptide.com/ar/23/en/?p=1811/#peopleachievements2023 |
|
Performance indicators |
Supply chain engagement–Approach–Achievements and challenges in 2023 |
Page 36 |
https://report.polypeptide.com/ar/23/en/?p=1811/#supplychainengagementachievements2023 |
|
|
People–Approach–Achievements and challenges in 2023 |
Page 37-39 |
https://report.polypeptide.com/ar/23/en/?p=1811/#peopleachievements2023 |
|
Combating corruption |
Business ethics and compliance |
Page 39-41 |
https://report.polypeptide.com/ar/23/en/?p=1811/#businessethicsandcompliance |
|
Main impacts, risks and opportunities |
Business ethics and compliance–Impact |
Page 39 |
https://report.polypeptide.com/ar/23/en/?p=1811/#businessethicsandcomplianceimpact |
|
|
Business ethics and compliance–Risks and opportunities |
Page 40 |
https://report.polypeptide.com/ar/23/en/?p=1811/#businessethicsandcompliancerisksandopportunities |
|
Policies adopted, including the due diligence applied |
Business ethics and compliance–Approach–Policies and commitments |
Page 40 |
https://report.polypeptide.com/ar/23/en/?p=1811/#businessethicsandcompliancepoliciesandcommitments |
|
Measures taken to implement policies and assessment of effectiveness |
Business ethics and compliance–Approach–Management of impacts, risks and opportunities |
Page 41 |
https://report.polypeptide.com/ar/23/en/?p=1811/#businessethicsandcompliancemanagement |
|
|
Business ethics and compliance–Approach–Achievements and challenges in 2023 |
Page 41 |
https://report.polypeptide.com/ar/23/en/?p=1811/#businessethicsandcomplianceachievements2023 |
|
Performance indicators |
Business ethics and compliance–Approach–Achievements and challenges in 2023 |
Page 41 |
https://report.polypeptide.com/ar/23/en/?p=1811/#businessethicsandcomplianceachievements2023 |
|
References to national, European or international regulations |
Introduction |
Page 18 |
|
|
GRI content index |
Page 48-51 |
||
|
Coverage of subsidiaries |
Sustainability approach |
Page 19 |
|
Art. 964j-l CO requirements |
Section |
Reference |
Article links |
|
|
|
|
|
|
PolyPeptide’s due diligence in relation to minerals and metals from conflict-affected areas |
Supply chain engagement–Approach |
Page 35-36 |
https://report.polypeptide.com/ar/23/en/?p=1811/#supplychainengagementapproach |
|
PolyPeptide's voluntary report on child labor due diligence in its supply chain |
Page 45-47 |
||
|
PolyPeptide's due diligence in relation to child labor |
Supply chain engagement–Approach |
Page 35-36 |
https://report.polypeptide.com/ar/23/en/?p=1811/#supplychainengagementapproach |
|
|
PolyPeptide's voluntary report on child labor due diligence in its supply chain |
Page 45-47 |
The report on non-financial matters for the financial year 2023 was approved for publication by the Board of Directors on 8 March 2024, and will be presented to the General Meeting of shareholders for a consultative vote on 10 April 2024.
Peter Wilden, Chair
Patrick Aebischer, Vice-Chair and Lead Independent Director
Jane Salik, Member
Erik Schropp, Member
Beat In-Albon, Independent Member
Philippe Weber, Independent Member
Dorothee A. Deuring, Independent Member
Baar, 12 March 2024
On behalf of the entire Board of Directors and the Executive Committee,
Peter Wilden
Chair of the Board of Directors
Juan José González
CEO